BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19608671)

  • 1. Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.
    Quintanilla-Martinez L; Slotta-Huspenina J; Koch I; Klier M; Hsi ED; de Leval L; Klapper W; Gesk S; Siebert R; Fend F
    Haematologica; 2009 Nov; 94(11):1595-8. PubMed ID: 19608671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
    Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
    Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
    Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
    Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
    J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
    Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
    Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
    Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
    Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
    Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
    Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
    Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y
    Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].
    Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Aguilera NS; Bijwaard KE; Duncan B; Krafft AE; Chu WS; Abbondanzo SL; Lichy JH; Taubenberger JK
    Am J Pathol; 1998 Dec; 153(6):1969-76. PubMed ID: 9846986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathologic diagnosis of mantle cell lymphoma.
    Li S; Xu J; You MJ
    Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
    Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders.
    Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
    Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.